Skip to product information
1 of 1

Aequum Pharmaceuticals Ltd.

Bortezomibum

Bortezomibum

⚠️ Supply Conditions & Intended Use

🔒 PROFESSIONAL USE ONLY
This product is available only for holders of a valid Wholesale Distribution Authorization (WDL) or Pharmacy License. License verification will be required prior to dispatch.

🚑 SHORTAGE RELIEF SUPPLY
This inventory is sourced globally to solve critical drug shortages in the EU. Available strictly for Special Import Procedures (e.g., Targeted Import, Unauthorized Medicine, Compassionate Use, §73.3 AMG).

Bortezomib;Bortezomibum;Bortezomib; Bortezomibum

Indication: Cancer

Authorized Market: Poland and Malta

Dosage Forms: Solution

Strength: 2.5 mg/ml

CMS: France; Spain; Italy

RMS: Germany

View full details